The objective of this proposal is to elucidate the mechanisms whereby diabetes impairs anestheticinduced preconditioning (ARC) with the goal of reducing perioperative cardiovascular morbidity and mortality in high-risk patients. A growing body of evidence implicates endothelial nitric oxide synthase (eNOS)- derived NO- and downstream effects on mitochondria! function and adenosine triphosphate-regulated potassium (KArp) channels as critical mediators of ARC. The current proposal will test the hypothesis that diabetes and hyperglycemia impair ARC signal transduction mechanisms in the heart through an eNOS-sensitive pathway involving HSP90, tetrahydrobiopterin (BH4), asymmetric dimethylarginine (ADMA), KATp channels, and mitochondria;and that this pathway can be favorably modulated with pharmacological and genetic strategies targeted at NO* signaling and mitochondrial function (mitochondrial genome switch). During Specific Aim 1, we will evaluate the hypotheses that ARC enhances NO signaling by promoting eNOS coupling (production of NO- and not superoxide anion) through mechanisms that involve decreased production of ADMA, increased availability of BH4, and enhanced interactions between HSP90 and eNOS. We propose that ARC improves mitochondrial bioenergetics (ATP production, respiration, mitochondrial membrane potential) after myocardial ischemia and reperfusion, and enhances KATP channel activity in an NO* dependent fashion, and conversely, that these beneficial effects are abolished by diabetes and hyperglycemia. During Specific Aim 2, we will address the hypotheses that targeting specific components of ARC signal transduction pathways by using pharmacological and genetic strategies to improve eNOS function and enhance mitochondrial bioenergetics will restore ARC protection during diabetes. The proposal will exploit a novel model of type 2 diabetes in the rat in which we are able to selectively switch the mitochondrial genome in order to further dissect the role of mitochondria during impaired ARC. Exciting preliminary data indicate that ARC is restored in diabetic rats after mitochondrial genome switch. These experiments will provide novel mechanistic information on the role of eNOS regulation, mitochondrial function, diabetes, and hyperglycemia to modulate anestheticinduced cardioprotection through protein-protein interactions;protein phosphorylation/tyrosine nitration; altered co-factor availability and ROS formation;and through decreased KATP channel activity using novel genetic and pharmalogical approaches in vivo and in engineered heart tissue, isolated hearts, and cells in vitro. The results will also suggest new therapeutic targets for intervention in patients with diabetes. Lay description: Individuals with diabetes are at increased risk for cardiovascular complications following anesthesia and surgery. The proposed research will define the mechanisms whereby diabetes impairs the cardioprotective effects of anesthetics and will identify new potential treatments for diabetes and hyperglycemia.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM066730-09
Application #
8305023
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2011-08-01
Budget End
2012-07-31
Support Year
9
Fiscal Year
2011
Total Cost
$399,536
Indirect Cost
Name
Medical College of Wisconsin
Department
Type
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Liu, Yong; Usa, Kristie; Wang, Feng et al. (2018) MicroRNA-214-3p in the Kidney Contributes to the Development of Hypertension. J Am Soc Nephrol 29:2518-2528
Zhang, Xiao; Dash, Ranjan K; Jacobs, Elizabeth R et al. (2018) Integrated computational model of the bioenergetics of isolated lung mitochondria. PLoS One 13:e0197921
Ghanian, Zahra; Konduri, Girija Ganesh; Audi, Said Halim et al. (2018) Quantitative optical measurement of mitochondrial superoxide dynamics in pulmonary artery endothelial cells. J Innov Opt Health Sci 11:
Liang, Mingyu (2018) Epigenetic Mechanisms and Hypertension. Hypertension 72:1244-1254
Pant, Tarun; Dhanasekaran, Anuradha; Fang, Juan et al. (2018) Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy. BMC Cardiovasc Disord 18:197
Ge, Zhi-Dong; Li, Yingchuan; Qiao, Shigang et al. (2018) Failure of Isoflurane Cardiac Preconditioning in Obese Type 2 Diabetic Mice Involves Aberrant Regulation of MicroRNA-21, Endothelial Nitric-oxide Synthase, and Mitochondrial Complex I. Anesthesiology 128:117-129
Williams, Anna Marie; Liu, Yong; Regner, Kevin R et al. (2018) Artificial intelligence, physiological genomics, and precision medicine. Physiol Genomics 50:237-243
Liu, Pengyuan; Liu, Yong; Liu, Han et al. (2018) Role of DNA De Novo (De)Methylation in the Kidney in Salt-Induced Hypertension. Hypertension 72:1160-1171
Chuppa, Sandra; Liang, Mingyu; Liu, Pengyuan et al. (2018) MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4. Kidney Int 93:375-389
Korman, Ben; Dash, Ranjan K; Peyton, Philip J (2018) Can Mathematical Modeling Explain the Measured Magnitude of the Second Gas Effect? Anesthesiology 128:1075-1083

Showing the most recent 10 out of 134 publications